纵横研报
Ticker Detail

600129.SHG

¥17.98+1.99% 太极集团 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Chongqing Taiji Industry Group Co Ltd
医疗健康 · 专科与仿制药

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascular, big health, anti-infective, anti-tumor, immunomodulatory drugs; and anti-aging products. It also engages in accommodation, loading and unloading, warehousing, catering, retail, agriculture, wholesale, and aquaculture activities; and research and development of medicinal herb planting. Chongqing Taiji Industry(Group) Co.,Ltd was incorporated in 1979 and is headquartered in Chongqing, China.

MARKET 市值 9.14B CNY PE 79.0x Fwd 41.5x 52W ¥11.56 – ¥25.51 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -10.6% ROE 3.0% 营业利润率 3.8% 净利润率 1.1%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制